ES3017694T3 - Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections - Google Patents
Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections Download PDFInfo
- Publication number
- ES3017694T3 ES3017694T3 ES18788687T ES18788687T ES3017694T3 ES 3017694 T3 ES3017694 T3 ES 3017694T3 ES 18788687 T ES18788687 T ES 18788687T ES 18788687 T ES18788687 T ES 18788687T ES 3017694 T3 ES3017694 T3 ES 3017694T3
- Authority
- ES
- Spain
- Prior art keywords
- vaginal
- compound
- infection
- formula
- spp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Polyesters Or Polycarbonates (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17195192 | 2017-10-06 | ||
| PCT/EP2018/077129 WO2019068862A1 (en) | 2017-10-06 | 2018-10-05 | GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND / OR PREVENTION OF MICROBIAL INFECTIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES3017694T3 true ES3017694T3 (en) | 2025-05-13 |
Family
ID=60185986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18788687T Active ES3017694T3 (en) | 2017-10-06 | 2018-10-05 | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11612584B2 (enExample) |
| EP (1) | EP3691625B1 (enExample) |
| JP (1) | JP7424636B2 (enExample) |
| KR (1) | KR102650182B1 (enExample) |
| CN (1) | CN111182895B (enExample) |
| AU (1) | AU2018346361B2 (enExample) |
| BR (1) | BR112020006931A2 (enExample) |
| CA (1) | CA3078451A1 (enExample) |
| CL (1) | CL2020000859A1 (enExample) |
| EA (1) | EA202090750A1 (enExample) |
| ES (1) | ES3017694T3 (enExample) |
| HU (1) | HUE070746T2 (enExample) |
| IL (1) | IL273297B2 (enExample) |
| MX (1) | MX2020003660A (enExample) |
| MY (1) | MY205944A (enExample) |
| PH (1) | PH12020550222A1 (enExample) |
| PL (1) | PL3691625T3 (enExample) |
| SG (1) | SG11202002494WA (enExample) |
| UA (1) | UA126590C2 (enExample) |
| WO (1) | WO2019068862A1 (enExample) |
| ZA (1) | ZA202001605B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019068862A1 (en) | 2017-10-06 | 2019-04-11 | Gedea Biotech Ab | GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND / OR PREVENTION OF MICROBIAL INFECTIONS |
| MA56011A (fr) | 2019-04-05 | 2022-04-06 | Gedea Biotech Ab | Formulation de comprimé vaginal |
| CN114751878B (zh) * | 2022-03-29 | 2023-06-16 | 青岛农业大学 | 一种BcTol1基因靶向剂及其应用 |
| EP4731203A1 (en) * | 2023-06-22 | 2026-04-29 | Gedea Biotech AB | Compositions for promoting growth of lactobacillus crispatus |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1278868B1 (it) | 1995-10-27 | 1997-11-28 | Sanitaria Scaligera Spa | Metodo per l'ottenimento di un materiale riassorbibile atto ad essere utilizzato come elemento di rivestimento per la prevenzione di |
| AUPP839499A0 (en) | 1999-01-29 | 1999-02-25 | Australian National University, The | A method for controlling plant pathogens, and agents useful for same |
| JP3745612B2 (ja) | 2000-10-31 | 2006-02-15 | 西川ゴム工業株式会社 | ポリヒドロキシカルボン酸の製造方法 |
| US20060172007A1 (en) * | 2001-05-01 | 2006-08-03 | Nawaz Ahmad | Compositions and methods for reducing vaginal pH |
| US20030017207A1 (en) * | 2001-05-01 | 2003-01-23 | Lin Shun Y. | Compositions and methods for treating vulvovaginitis and vaginosis |
| US20060105008A1 (en) * | 2002-03-28 | 2006-05-18 | Nawaz Ahmad | Compositions and methods for reducing vaginal pH |
| US7569530B1 (en) | 2003-06-20 | 2009-08-04 | The Procter & Gamble Company | Antimicrobial compositions, products and methods employing same |
| CA2487270C (en) | 2002-06-21 | 2010-10-26 | The Procter & Gamble Company | Antimicrobial compositions, products and methods employing same |
| US7547454B2 (en) * | 2002-11-07 | 2009-06-16 | Shyam K Gupta | Hydroxy acid complexes for antiaging and skin renovation |
| US20040126369A1 (en) * | 2002-12-30 | 2004-07-01 | Richard Payne | Delivery of peroxide-generating enzymes to the vaginal tract |
| US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
| US20050260243A1 (en) * | 2004-04-26 | 2005-11-24 | The Procter & Gamble Company | Method of treating microbial plant diseases |
| US20050271711A1 (en) | 2004-04-26 | 2005-12-08 | The Procter & Gamble Company | Therapeutic antimicrobial compositions and methods |
| AU2006209263A1 (en) | 2005-09-12 | 2007-03-29 | Mcneil-Ppc, Inc. | Anhydrous composition containing an acid-acid buffer system |
| US20070059278A1 (en) | 2005-09-12 | 2007-03-15 | Nawaz Ahmad | Anhydrous composition containing an acid-acid buffer system |
| US20080058421A1 (en) | 2006-09-05 | 2008-03-06 | John Alex Lopes | Compositions for cleaning and disinfecting nasal tract and sinus cavity |
| WO2008108834A2 (en) * | 2006-11-09 | 2008-09-12 | Northwestern University | Inhibitors of the mevalonate pathway of streptococcus pneumoniae |
| JP2008283893A (ja) * | 2007-05-16 | 2008-11-27 | Sumitomo Chemical Co Ltd | 家禽用コクシジウム感染抑制剤及びそれを用いたコクシジウム感染抑制方法 |
| US20100285095A1 (en) * | 2009-05-05 | 2010-11-11 | Kimberly Ann Nemeth | Hygiene Article Having Calcium Sugar Acid Salt |
| CN102070774B (zh) | 2010-11-25 | 2012-08-22 | 华南师范大学 | 单糖或其糖醇与乳酸的共聚物的制备方法 |
| EP2704694A4 (en) | 2011-05-02 | 2014-11-19 | Aptalis Pharmatech Inc | RAPID DISSOLUTION TABLET COMPOSITIONS FOR VAGINAL DELIVERY |
| US9937214B2 (en) | 2013-11-08 | 2018-04-10 | Suzhou Osel Bio-Pharm Co., Ltd. | Lactobacillus crispatus and application thereof |
| DK178786B1 (en) * | 2015-03-11 | 2017-02-06 | Dantrace-Danfeed Ivs | Use of zinc and copper gluconate in the treatment of methicillin-resistant staphylococcus aureus |
| MX382396B (es) * | 2016-04-06 | 2025-03-13 | Gedea Biotech Ab | Glucono delta-lactona para el tratamiento de infecciones fúngicas vaginales. |
| CA3040422A1 (en) | 2016-10-13 | 2018-04-19 | Catalent U.K. Swindon Zydis Limited | Lyophilized pharmaceutical compositions for vaginal delivery |
| KR101841976B1 (ko) | 2017-06-07 | 2018-05-14 | 조영진 | 식물 추출물을 포함하는 항진균 및 항균 조성물 |
| WO2019068862A1 (en) | 2017-10-06 | 2019-04-11 | Gedea Biotech Ab | GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND / OR PREVENTION OF MICROBIAL INFECTIONS |
| MA56011A (fr) | 2019-04-05 | 2022-04-06 | Gedea Biotech Ab | Formulation de comprimé vaginal |
-
2018
- 2018-10-05 WO PCT/EP2018/077129 patent/WO2019068862A1/en not_active Ceased
- 2018-10-05 KR KR1020207010202A patent/KR102650182B1/ko active Active
- 2018-10-05 US US16/753,899 patent/US11612584B2/en active Active
- 2018-10-05 HU HUE18788687A patent/HUE070746T2/hu unknown
- 2018-10-05 ES ES18788687T patent/ES3017694T3/es active Active
- 2018-10-05 PL PL18788687.4T patent/PL3691625T3/pl unknown
- 2018-10-05 JP JP2020519028A patent/JP7424636B2/ja active Active
- 2018-10-05 CA CA3078451A patent/CA3078451A1/en active Pending
- 2018-10-05 CN CN201880065162.XA patent/CN111182895B/zh active Active
- 2018-10-05 EP EP18788687.4A patent/EP3691625B1/en active Active
- 2018-10-05 AU AU2018346361A patent/AU2018346361B2/en active Active
- 2018-10-05 SG SG11202002494WA patent/SG11202002494WA/en unknown
- 2018-10-05 IL IL273297A patent/IL273297B2/en unknown
- 2018-10-05 UA UAA202002422A patent/UA126590C2/uk unknown
- 2018-10-05 MX MX2020003660A patent/MX2020003660A/es unknown
- 2018-10-05 EA EA202090750A patent/EA202090750A1/ru unknown
- 2018-10-05 BR BR112020006931-0A patent/BR112020006931A2/pt active IP Right Grant
- 2018-10-05 MY MYPI2020001657A patent/MY205944A/en unknown
-
2020
- 2020-03-13 ZA ZA2020/01605A patent/ZA202001605B/en unknown
- 2020-03-31 CL CL2020000859A patent/CL2020000859A1/es unknown
- 2020-04-06 PH PH12020550222A patent/PH12020550222A1/en unknown
-
2023
- 2023-02-02 US US18/163,321 patent/US12226396B2/en active Active
-
2025
- 2025-01-08 US US19/013,187 patent/US20250144070A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202001605B (en) | 2023-12-20 |
| IL273297B1 (en) | 2024-02-01 |
| US11612584B2 (en) | 2023-03-28 |
| UA126590C2 (uk) | 2022-11-02 |
| EP3691625C0 (en) | 2025-02-19 |
| JP7424636B2 (ja) | 2024-01-30 |
| PL3691625T3 (pl) | 2025-05-12 |
| AU2018346361B2 (en) | 2024-07-25 |
| IL273297A (en) | 2020-04-30 |
| BR112020006931A2 (pt) | 2020-10-06 |
| EP3691625B1 (en) | 2025-02-19 |
| HUE070746T2 (hu) | 2025-07-28 |
| EP3691625A1 (en) | 2020-08-12 |
| WO2019068862A1 (en) | 2019-04-11 |
| US20200253925A1 (en) | 2020-08-13 |
| AU2018346361A1 (en) | 2020-05-14 |
| US12226396B2 (en) | 2025-02-18 |
| US20230181523A1 (en) | 2023-06-15 |
| CL2020000859A1 (es) | 2020-10-02 |
| PH12020550222A1 (en) | 2021-02-15 |
| MX2020003660A (es) | 2020-08-03 |
| IL273297B2 (en) | 2024-06-01 |
| JP2020536862A (ja) | 2020-12-17 |
| SG11202002494WA (en) | 2020-04-29 |
| CN111182895B (zh) | 2024-05-14 |
| KR102650182B1 (ko) | 2024-03-21 |
| CN111182895A (zh) | 2020-05-19 |
| CA3078451A1 (en) | 2019-04-11 |
| EA202090750A1 (ru) | 2020-11-11 |
| MY205944A (en) | 2024-11-21 |
| US20250144070A1 (en) | 2025-05-08 |
| KR20200060413A (ko) | 2020-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12226396B2 (en) | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections | |
| Lucarini et al. | Unsaturated fatty acids lactose esters: Cytotoxicity, permeability enhancement and antimicrobial activity | |
| JP2019513769A (ja) | アトピー性皮膚炎を処置するためのグラム陰性種の使用 | |
| ES2532884T3 (es) | Composición vaginal a base de alquilpoliglucósidos | |
| JP6416207B2 (ja) | 抗ウイルスゲル配合剤 | |
| CN105232526A (zh) | 含儿茶素的药物在制备抑菌药物中的用途 | |
| CN109069413B (zh) | 用于治疗阴道真菌感染的葡萄糖酸δ-内酯 | |
| Refat et al. | Formulation and evaluation of yemeni potash alum as hydrophilic topical preparations against candidiasis and aspergillosis | |
| HK40029669A (en) | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections | |
| HK40029669B (en) | Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections | |
| AU2023202580A1 (en) | Compositions for sexually transmitted diseases | |
| ES2334746B1 (es) | Producto para la higiene intima a base de mirtillo rojo y procedimiento para su preparacion. | |
| RU2595852C1 (ru) | Антимикробные суппозитории | |
| KR20260006643A (ko) | 세균의 증식 억제제, 그것을 포함하는 화장품, 의약 부외품 및 의약 조성물, 그리고 세균의 증식 억제 방법 | |
| BR112018070370B1 (pt) | Glucono delta-lactona para tratamento de candidíase vulvovaginal |